封面
市场调查报告书
商品编码
1681797

2025年生命科学领域人工智慧全球市场报告

Artificial Intelligence In Life Sciences Global Market Report 2025

出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年生命科学领域人工智慧的市场规模将呈指数级增长。到 2029 年,这一数字将成长至 84.5 亿美元,复合年增长率为 23.7%。预测期内的成长可归因于人们对即时远端患者监护(rpm) 系统的兴趣日益浓厚、药物发现中对人工智慧的需求不断增加以及医学影像分析中对人工智慧的采用日益增多。预测期内的关键趋势包括策略伙伴关係、产品创新、技术进步、投资和研究与开发。

人们对即时远端患者监护(RPM)系统日益增长的兴趣可能会暂时推动人工智慧在生命科学市场的扩张。远端患者监护系统采用科技主导的医疗保健解决方案,旨在超越传统医疗环境监控病人的健康状况。在生命科学领域,人工智慧在远端患者监护中发挥关键作用,提供持续、个人化、资料主导的洞察,以促进主动的医疗管理。美国数位医疗公司 Vivalink 的一项调查显示,临床医生采用远端患者监护(RPM) 的比例将显着增加,从 2021 年的 20% 增加到 2022 年的 81%,增幅高达 305%。因此,人们对即时远端患者监护(RPM) 系统的兴趣日益浓厚,刺激了生命科学市场人工智慧的发展。

为了维持市场地位,生命科学人工智慧市场的主要企业正专注于具有技术进步的创新产品,例如药物发现软体。药物发现软体由旨在协助製药和生物技术研究人员进行药物发现过程的电脑程式和应用程式组成。 2023年12月,总部位于德国的科技公司默克公司推出了突破性的药物发现软体AIDDISON。 AIDDISON 是世界上第一个利用生成式人工智慧、机器学习和电脑辅助药物设计将虚拟分子设计与现实世界的可製造性相结合的药物发现软体。 AIDDISON 擅长从大量候选药物中筛选出合适的药物,同时考虑到药物的无毒性和溶解性等基本特性。其独特的弥合虚拟分子设计与现实世界可製造性之间差距的能力凸显了人工智慧在生命科学领域的卓越应用。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场 - 宏观经济情景,包括利率、通膨、地缘政治、新冠疫情以及復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球生命科学人工智慧PESTEL分析(政治、社会、技术、环境、法律因素、驱动因素、限制因素)
  • 最终用途产业分析
  • 全球生命科学人工智慧市场:成长率分析
  • 全球生命科学人工智慧市场表现:规模与成长,2019-2024
  • 全球生命科学人工智慧市场预测:规模与成长,2024-2029 年,2034 年预测
  • 生命科学领域全球人工智慧总目标市场(TAM)

第六章市场区隔

  • 全球生命科学领域人工智慧市场(按产品、表现和预测),2019-2024 年、2024-2029 年、2034 年
  • 软体
  • 硬体
  • 服务
  • 全球生命科学领域人工智慧市场:依部署、表现及预测,2019-2024 年、2024-2029 年、2034 年
  • 本地
  • 云端基础
  • 全球生命科学领域人工智慧市场:应用、绩效与预测(2019-2024 年、2024-2029 年及 2034 年)
  • 药物研发
  • 医疗诊断
  • 生物技术
  • 临床试验
  • 精准个人化医疗
  • 病患监测
  • 全球生命科学人工智慧市场、软体细分、按类型、效能和预测,2019-2024 年、2024-2029 年、2034 年
  • 药物研发软体
  • 基因组分析软体
  • 临床试验管理软体
  • 个人化医疗软体
  • 实验室资讯管理系统(LIMS)
  • 全球生命科学人工智慧市场、硬体细分、按类型、效能和预测,2019-2024 年、2024-2029 年、2034 年
  • 人工智慧实验室设备
  • 机器人和自动化系统
  • 成像设备和器材
  • 感测器技术
  • 全球生命科学领域人工智慧市场,依服务类型、绩效及预测细分,2019-2024 年、2024-2029 年、2034 年
  • 咨询服务
  • 资料分析服务
  • 研发服务
  • 实施和整合服务
  • 培训和支援服务

第七章 区域和国家分析

  • 全球生命科学人工智慧市场:按地区、绩效及预测,2019-2024 年、2024-2029 年、2034 年
  • 全球生命科学领域人工智慧市场:依国家、表现及预测,2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章:中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章:义大利市场

第20章:西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章:加拿大市场

第26章 南美洲市场

第27章:巴西市场

第28章 中东市场

第29章:非洲市场

第30章竞争格局与公司概况

  • 生命科学领域的人工智慧:竞争格局
  • 生命科学市场中的人工智慧:公司简介
    • Google LLC Overview, Products and Services, Strategy and Financial Analysis
    • Microsoft Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Intel Corporation Overview, Products and Services, Strategy and Financial Analysis
    • IBM Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

  • Nvidia Corporation
  • Novo Nordisk A/S
  • Siemens Healthineers AG
  • Philips Healthcare
  • Babylon Healthcare Services Ltd.
  • Komodo Health Inc.
  • Modernizing Medicine Inc.
  • Viz.ai Inc.
  • Butterfly Network Inc.
  • Augmedix
  • AiCure LLC
  • HealthTap Inc.
  • Welltok Inc.
  • Enlitic Inc.
  • PathAI Inc.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

  • 2029年生命科学市场中的人工智慧:提供新机会的国家
  • 2029年生命科学市场中的人工智慧:提供新机会的细分市场
  • 2029年生命科学市场中的人工智慧:成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第36章 附录

简介目录
Product Code: r27399

Artificial intelligence (AI) in life sciences involves the application of AI technologies and techniques across various domains within the life sciences industry. The integration of AI aims to enhance and expedite processes, improve decision-making, and extract valuable insights from complex data sets.

The primary components of artificial intelligence in life sciences include software, hardware, and services. The software employs AI algorithms to analyze extensive chemical databases, predicting the likelihood of specific molecules binding to target receptors, thereby accelerating the drug discovery process. These software applications can be deployed through on-premises and cloud-based models and find applications in various domains such as drug discovery, medical diagnosis, biotechnology, clinical trials, precision and personalized medicine, and patient monitoring.

The artificial intelligence in life sciences market research report is one of a series of new reports from The Business Research Company that provides artificial intelligence in life sciences market statistics, including artificial intelligence in life sciences industry global market size, regional shares, competitors with artificial intelligence in life sciences market share, detailed artificial intelligence in life science market segments, market trends, and opportunities, and any further data you may need to thrive in the artificial intelligence in life sciences industry. This artificial intelligence in life sciences market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The artificial intelligence in life sciences market size has grown exponentially in recent years. It will grow from $2.92 billion in 2024 to $3.61 billion in 2025 at a compound annual growth rate (CAGR) of 23.7%. The growth in the historic period can be attributed to increasing number of clinical trials, increasing adoption of ai in the domain of research and development, high emphasis on the development of precision medicine and personalized drugs.

The artificial intelligence in life sciences market size is expected to see exponential growth in the next few years. It will grow to $8.45 billion in 2029 at a compound annual growth rate (CAGR) of 23.7%. The growth in the forecast period can be attributed to the increasing interest in real-time remote patient monitoring (rpm) systems, increasing demand for AI in drug discovery, the increasing adoption of ai in medical imaging analysis. Major trends in the forecast period include strategic partnership, product innovations, technological advancements, investments, research and developments.

The growing interest in real-time remote patient monitoring (RPM) systems is set to drive the expansion of artificial intelligence in the life sciences market in the foreseeable future. Remote patient monitoring systems, characterized by technology-driven healthcare solutions, aim to monitor patients' health beyond traditional healthcare settings. In the life sciences domain, AI plays a pivotal role in remote patient monitoring, offering continuous, personalized, and data-driven insights that facilitate proactive healthcare management. A survey conducted by Vivalink, a US-based digital healthcare company, revealed a noteworthy surge in clinicians' adoption of remote patient monitoring (RPM), growing from 20% in 2021 to 81% in 2022, representing a substantial 305% increase. Consequently, the rising interest in real-time remote patient monitoring (RPM) systems is steering the growth of artificial intelligence in the life sciences market.

Leading companies operating in the artificial intelligence in the life sciences market are directing their efforts towards innovative products featuring technological advancements, exemplified by drug discovery software, to maintain their market standing. Drug discovery software comprises computer programs and applications tailored to assist researchers in the pharmaceutical and biotechnology sectors during the drug discovery process. In December 2023, Merck, a Germany-based science and technology company, unveiled AIDDISON, a revolutionary drug discovery software. Positioned as the first of its kind, AIDDISON integrates virtual molecule design with real-world manufacturability, leveraging generative AI, machine learning, and computer-aided drug design. AIDDISON excels in identifying drug candidates from a vast array of possibilities, considering essential properties such as non-toxicity and solubility. Its unique capability to bridge the gap between virtual molecule design and real-world manufacturability underscores a notable application of artificial intelligence in the life sciences sector.

In June 2023, Verix, a US-based company specializing in pharma commercial operations, completed the acquisition of Start-up.AI for an undisclosed sum. Verix's strategic move to acquire Start-up.AI aims to fortify its capabilities in artificial intelligence (AI) and machine learning (ML) within the pharmaceutical commercial operations sector. Start-up.ai, based in Israel, is a provider of an AI-driven commercial optimization platform, enhancing Verix's prowess in life science AI capabilities.

Major companies operating in the artificial intelligence in life sciences market report are Google LLC, Microsoft Corporation, Intel Corporation, IBM Corporation, Medtronic PLC, Nvidia Corporation, Novo Nordisk A/S, Siemens Healthineers AG, Philips Healthcare, Babylon Healthcare Services Ltd., Komodo Health Inc., Modernizing Medicine Inc., Viz.ai Inc., Butterfly Network Inc., Agueda, AiCure LLC, HealthTap Inc., Welltok Inc., Enlitic Inc., PathAI Inc., Nano-X Imaging Ltd., Berg LLC, Inserto, Sense.ly Inc., Subtle Medical Inc., Med sense Biometrics Limited, Immune, Atomwise Inc., Freenome Holdings Inc., Clouded Inc.

North America was the largest region in the Artificial Intelligence In Life Sciences market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence in life sciences market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the artificial intelligence (AI) in the life sciences market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The artificial intelligence (AI) in the life sciences market consists of revenues earned by entities by private analytics, AI-driven clinical trial services, and real-world evidence services. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence (AI) in the life sciences market also consists of sales of high-performance computing (HPC) clusters, edge computing devices, and IoT devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Artificial Intelligence In Life Sciences Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on artificial intelligence in life sciences market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for artificial intelligence in life sciences ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The artificial intelligence in life sciences market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Offering: Software; Hardware; Services
  • 2) By Deployment: On-Premises; Cloud-Based
  • 3) By Application: Drug Discovery; Medical Diagnosis; Biotechnology; Clinical Trails; Precision And Personalized Medicine; Patient Monitoring
  • Subsegments:
  • 1) By Software: Drug Discovery Software; Genomic Analysis Software; Clinical Trial Management Software; Personalized Medicine Software; Laboratory Information Management Systems (LIMS)
  • 2) By Hardware: AI-Enabled Laboratory Equipment; Robotics And Automation Systems; Imaging Devices And Equipment; Sensor Technologies
  • 3) By Services: Consulting Services; Data Analytics Services; Research And Development Services; Implementation And Integration Services; Training And Support Services
  • Companies Mentioned: Google LLC; Microsoft Corporation; Intel Corporation; IBM Corporation; Medtronic PLC
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Artificial Intelligence In Life Sciences Market Characteristics

3. Artificial Intelligence In Life Sciences Market Trends And Strategies

4. Artificial Intelligence In Life Sciences Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Artificial Intelligence In Life Sciences Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Artificial Intelligence In Life Sciences PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Artificial Intelligence In Life Sciences Market Growth Rate Analysis
  • 5.4. Global Artificial Intelligence In Life Sciences Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Artificial Intelligence In Life Sciences Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Artificial Intelligence In Life Sciences Total Addressable Market (TAM)

6. Artificial Intelligence In Life Sciences Market Segmentation

  • 6.1. Global Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Software
  • Hardware
  • Services
  • 6.2. Global Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • On-Premises
  • Cloud-Based
  • 6.3. Global Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Drug Discovery
  • Medical Diagnosis
  • Biotechnology
  • Clinical Trials
  • Precision And Personalized Medicine
  • Patient Monitoring
  • 6.4. Global Artificial Intelligence In Life Sciences Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Drug Discovery Software
  • Genomic Analysis Software
  • Clinical Trial Management Software
  • Personalized Medicine Software
  • Laboratory Information Management Systems (LIMS)
  • 6.5. Global Artificial Intelligence In Life Sciences Market, Sub-Segmentation Of Hardware, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • AI-Enabled Laboratory Equipment
  • Robotics And Automation Systems
  • Imaging Devices And Equipment
  • Sensor Technologies
  • 6.6. Global Artificial Intelligence In Life Sciences Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Consulting Services
  • Data Analytics Services
  • Research And Development Services
  • Implementation And Integration Services
  • Training And Support Services

7. Artificial Intelligence In Life Sciences Market Regional And Country Analysis

  • 7.1. Global Artificial Intelligence In Life Sciences Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Artificial Intelligence In Life Sciences Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Artificial Intelligence In Life Sciences Market

  • 8.1. Asia-Pacific Artificial Intelligence In Life Sciences Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Artificial Intelligence In Life Sciences Market

  • 9.1. China Artificial Intelligence In Life Sciences Market Overview
  • 9.2. China Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Artificial Intelligence In Life Sciences Market

  • 10.1. India Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Artificial Intelligence In Life Sciences Market

  • 11.1. Japan Artificial Intelligence In Life Sciences Market Overview
  • 11.2. Japan Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Artificial Intelligence In Life Sciences Market

  • 12.1. Australia Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Artificial Intelligence In Life Sciences Market

  • 13.1. Indonesia Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Artificial Intelligence In Life Sciences Market

  • 14.1. South Korea Artificial Intelligence In Life Sciences Market Overview
  • 14.2. South Korea Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Artificial Intelligence In Life Sciences Market

  • 15.1. Western Europe Artificial Intelligence In Life Sciences Market Overview
  • 15.2. Western Europe Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Artificial Intelligence In Life Sciences Market

  • 16.1. UK Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Artificial Intelligence In Life Sciences Market

  • 17.1. Germany Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Artificial Intelligence In Life Sciences Market

  • 18.1. France Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Artificial Intelligence In Life Sciences Market

  • 19.1. Italy Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Artificial Intelligence In Life Sciences Market

  • 20.1. Spain Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Artificial Intelligence In Life Sciences Market

  • 21.1. Eastern Europe Artificial Intelligence In Life Sciences Market Overview
  • 21.2. Eastern Europe Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Artificial Intelligence In Life Sciences Market

  • 22.1. Russia Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Artificial Intelligence In Life Sciences Market

  • 23.1. North America Artificial Intelligence In Life Sciences Market Overview
  • 23.2. North America Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Artificial Intelligence In Life Sciences Market

  • 24.1. USA Artificial Intelligence In Life Sciences Market Overview
  • 24.2. USA Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Artificial Intelligence In Life Sciences Market

  • 25.1. Canada Artificial Intelligence In Life Sciences Market Overview
  • 25.2. Canada Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Artificial Intelligence In Life Sciences Market

  • 26.1. South America Artificial Intelligence In Life Sciences Market Overview
  • 26.2. South America Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Artificial Intelligence In Life Sciences Market

  • 27.1. Brazil Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Artificial Intelligence In Life Sciences Market

  • 28.1. Middle East Artificial Intelligence In Life Sciences Market Overview
  • 28.2. Middle East Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Artificial Intelligence In Life Sciences Market

  • 29.1. Africa Artificial Intelligence In Life Sciences Market Overview
  • 29.2. Africa Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Artificial Intelligence In Life Sciences Market Competitive Landscape And Company Profiles

  • 30.1. Artificial Intelligence In Life Sciences Market Competitive Landscape
  • 30.2. Artificial Intelligence In Life Sciences Market Company Profiles
    • 30.2.1. Google LLC Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Microsoft Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Intel Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. IBM Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis

31. Artificial Intelligence In Life Sciences Market Other Major And Innovative Companies

  • 31.1. Nvidia Corporation
  • 31.2. Novo Nordisk A/S
  • 31.3. Siemens Healthineers AG
  • 31.4. Philips Healthcare
  • 31.5. Babylon Healthcare Services Ltd.
  • 31.6. Komodo Health Inc.
  • 31.7. Modernizing Medicine Inc.
  • 31.8. Viz.ai Inc.
  • 31.9. Butterfly Network Inc.
  • 31.10. Augmedix
  • 31.11. AiCure LLC
  • 31.12. HealthTap Inc.
  • 31.13. Welltok Inc.
  • 31.14. Enlitic Inc.
  • 31.15. PathAI Inc.

32. Global Artificial Intelligence In Life Sciences Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Artificial Intelligence In Life Sciences Market

34. Recent Developments In The Artificial Intelligence In Life Sciences Market

35. Artificial Intelligence In Life Sciences Market High Potential Countries, Segments and Strategies

  • 35.1 Artificial Intelligence In Life Sciences Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Artificial Intelligence In Life Sciences Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Artificial Intelligence In Life Sciences Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer